0001384101-18-000070.txt : 20180810 0001384101-18-000070.hdr.sgml : 20180810 20180810171032 ACCESSION NUMBER: 0001384101-18-000070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180809 FILED AS OF DATE: 20180810 DATE AS OF CHANGE: 20180810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hall Christopher M CENTRAL INDEX KEY: 0001449535 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36156 FILM NUMBER: 181009656 MAIL ADDRESS: STREET 1: 1401 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERACYTE, INC. CENTRAL INDEX KEY: 0001384101 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 205455398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 243-6300 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: CALDEROME INC DATE OF NAME CHANGE: 20061219 4 1 wf-form4_153393541595179.xml FORM 4 X0306 4 2018-08-09 0 0001384101 VERACYTE, INC. VCYT 0001449535 Hall Christopher M 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 President and COO Common Stock 2018-08-09 4 M 0 4237 2.36 A 36692 D Common Stock 2018-08-09 4 M 0 8263 2.36 A 44955 D Common Stock 2018-08-09 4 M 0 7500 2.36 A 52455 D Common Stock 2018-08-09 4 S 0 20000 12 D 32455 D Stock Option (right to buy) 2.36 2018-08-09 4 M 0 4237 0 D 2020-09-27 Common Stock 4237.0 0 D Stock Option (right to buy) 2.36 2018-08-09 4 M 0 8263 0 D 2010-09-27 Common Stock 8263.0 0 D Stock Option (right to buy) 2.36 2018-08-09 4 M 0 7500 0 D 2021-02-22 Common Stock 7500.0 3500 D The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. The option becomes exercisable as to 25% of the shares on September 28, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. The option became exercisable in full upon the date of the grant on February 23, 2011. /s/ Keith Kennedy, as Attorney-in-fact 2018-08-10